NEW YORK (GenomeWeb News) – The US Food and Drug Administration plans to formally launch its newly formed Serious Adverse Events Consortium in “the next couple of weeks,” an FDA official told GenomeWeb News today.
 
As GenomeWeb News reported this morning, the FDA is forming a consortium of drugmakers and academic research groups that aims to study how genetic biomarkers contribute to serious adverse events.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.